secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0001493152-24-031266
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stereotaxis Q2 revenue down 43% to $4.5M; net loss $5.8M; expects H2 revenue >$14M
--------------------------------------------------------------------------------

- Q2 revenue $4.5M vs $7.9M prior year; system revenue $0.2M due to hospital construction delays.
- Net loss $5.8M, adjusted net loss $3.3M; operating loss $6.0M, adjusted $3.5M.
- Cash and cash equivalents $15.2M at June 30, 2024, no debt; year-end cash target ~$13M.
- CE mark obtained for GenesisX, 510(k) submitted in US; acquisition of Access Point Technologies closed.
- Full-year revenue expected approximately equal to prior year; H2 revenue >$14M from stable recurring and Genesis shipments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000149315224031266/0001493152-24-031266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000149315224031266/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-031266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer